|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Acumen Pharmaceuticals, Inc. (ABOS) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
40,470,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$ - $ |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Acumen Pharmaceuticals discovers and develops targeted therapies for the treatment of Alzheimer's disease. Co.'s primary drug candidate, ACU193, is a humanized monoclonal antibody which selectively targets amyloid-beta oligomers. Co. holds exclusive rights to the program.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
5,161,290 |
5,161,290 |
Total Buy Value |
$0 |
$0 |
$39,999,998 |
$39,999,998 |
Total People Bought |
0 |
0 |
1 |
1 |
Total Buy Transactions |
0 |
0 |
1 |
1 |
Total Shares Sold |
0 |
34,332 |
76,281 |
76,281 |
Total Sell Value |
$0 |
$121,677 |
$394,011 |
$394,011 |
Total People Sold |
0 |
5 |
6 |
6 |
Total Sell Transactions |
0 |
5 |
6 |
6 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Shah Rajeev M. |
Director |
|
2021-07-06 |
4 |
B |
$16.00 |
$30,000,000 |
I/I |
1,875,000 |
1,300,034 |
2.25 |
- |
|
Hardie Robert D. |
10% Owner |
|
2021-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,608,469 |
657,985 |
|
- |
|
Hardie Robert D. |
10% Owner |
|
2021-07-06 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
3,352,693 |
1.5 |
- |
|
Zuga Matt |
Chief Financial Officer |
|
2021-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
26,187 |
26,187 |
|
- |
|
Hardie Robert D. |
10% Owner |
|
2021-07-06 |
4 |
B |
$16.00 |
$12,000,000 |
I/I |
750,000 |
3,951,156 |
1.5 |
- |
|
Hardie Robert D. |
10% Owner |
|
2021-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,201,156 |
3,201,156 |
|
- |
|
Oconnell Daniel Joseph |
President and CEO |
|
2021-07-06 |
4 |
D |
$16.00 |
$160 |
D/D |
(10) |
1,567 |
|
- |
|
Oconnell Daniel Joseph |
President and CEO |
|
2021-07-06 |
4 |
OE |
$4.47 |
$156 |
D/D |
35 |
1,577 |
|
- |
|
Oconnell Daniel Joseph |
President and CEO |
|
2021-07-06 |
4 |
A |
$0.00 |
$0 |
D/D |
123 |
1,542 |
|
- |
|
Fountain Nathan B |
Director |
|
2021-07-06 |
4 |
B |
$16.00 |
$100,000 |
D/D |
6,250 |
6,250 |
2.39 |
- |
|
Manning Paul B |
10% Owner |
|
2021-07-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,608,469 |
657,985 |
|
- |
|
Manning Paul B |
10% Owner |
|
2021-07-06 |
4 |
B |
$16.00 |
$5,000,000 |
I/I |
312,500 |
3,352,693 |
1.5 |
- |
|
37 Records found
|
|
Page 2 of 2 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|